Compounded Tirzepatide Prices Compared: Every Provider in 2026

Every price on this page was read directly from the provider's own website and legal pages on 11 August 2026, then annualised by us. Seven of the twelve providers pay us — Embody, Trimi Health, CoreAge Rx, Synergy Rx, Oak, Care Bare Rx and Direct Meds — and links to those seven are affiliate links, labelled as such. Ro, WellMedr, TrimRx, SkinnyRx and Bodybuilding Health+ pay us nothing. Ordering on this page is arithmetic, not payment. See our review method and affiliate disclosure.
The short version

Tirzepatide is where the price spread in this market gets genuinely strange. The same compounded molecule runs from roughly $1,500 a year at Trimi Health to roughly $4,188 a year at Synergy Rx — a difference of about $2,700 for a preparation neither company manufactures itself.

WellMedr's $99 looks like the cheapest number on the page and is not, because it renews every 21 days. Two providers we track sell a tirzepatide product and publish no price for it at all. And one provider, Ro, sells the FDA-approved branded version, Zepbound, which is not the same category of product as anything else here.

Check current Trimi Health pricing Compare all twelve providers

The Trimi Health link is an affiliate link. The comparison link is not.

Tirzepatide prices across every provider we track

Sorted by annualised cost, with the two providers that publish no price and the one FDA-approved option at the bottom.

Provider Product Advertised price Billing cycle Annualised cost Effective per calendar month
WellMedr Injectable compounded tirzepatide $99 Every 21 days — about 17.4 charges a year ~$1,721 ~$143
Trimi Health Injectable compounded tirzepatide $125 / month Monthly $1,500 $125
Embody Injectable compounded tirzepatide (GLP-1 + GIP) $129 / month (promotional) Monthly ~$1,548 ~$129
CoreAge Rx Injectable compounded tirzepatide $149 / month One-time purchase, refills ordered manually ~$1,788 ~$149
Bodybuilding Health+ Injectable compounded tirzepatide $159–$209 / month by term 1, 3, 6 or 12-month terms $1,908 – $2,508 $159–$209
TrimRx Injectable compounded GLP-1 + GIP from $259 / month Recurring subscription ~$3,108 ~$259
Direct Meds Injectable compounded GLP-1 (molecule not specified on the pricing FAQ) from $297 / month Every 30 days — about 12.17 charges a year ~$3,614 ~$301
SkinnyRx Injectable or tablet compounded tirzepatide from $299 / month ("as low as") Auto-renewing monthly, may be charged up to 5 days early ~$3,588 ~$299
Synergy Rx Injectable compounded tirzepatide $349 No billing period stated anywhere on the site ~$4,188 if monthly ~$349
Oak Compounded GLP-1 + GIP No separate price published — the site quotes programmes from $119/month without saying which product that covers Subscription, renews Not calculable Not calculable
Care Bare Rx Oral tirzepatide No price published — the weight-loss page contains no prices at all Not stated Not calculable Not calculable
Ro Zepbound — FDA-approved branded tirzepatide, insurance-first Membership $39 first month, then $149 / month, or as low as $74 / month prepaid. Medication billed separately. Monthly, or annually if you prepay $888 – $1,788 membership alone $74–$149 membership alone

The $99 tirzepatide that costs about $143 a month

WellMedr's compounded tirzepatide is the lowest advertised figure in this comparison at $99. Its own refund and cancellation policy says the subscription renews every 21 days. Multiply $99 across roughly 17.4 renewals and the year comes to about $1,721, or about $143 a calendar month — more than Trimi Health's $125 and more than Embody's promotional $129.

It is still mid-table rather than expensive, and we are reporting the policy rather than a bank statement because we have not been billed by them. But if you ranked this market on advertised price alone you would put WellMedr first on tirzepatide, and that would be wrong.

Tirzepatide versus semaglutide: what you are paying more for

Every provider that sells both charges more for tirzepatide, typically $26 to $150 a month more. Tirzepatide acts on two receptor pathways, GIP as well as GLP-1, which is why several of these companies market it as "GLP-1 + GIP" rather than by name. In the FDA-approved branded products the head-to-head trial evidence favours tirzepatide on average weight change.

That evidence was generated with FDA-approved branded medication, not with compounded preparations, and it does not automatically transfer. A compounded preparation has not been reviewed by the FDA for safety, effectiveness or manufacturing quality, and several of these providers quote branded trial statistics on pages selling compounded product. Treat the trial numbers as evidence about the molecule, not as a claim about the vial you will receive.

The clinical choice between the two is a conversation with a prescriber, not a purchasing decision. What we can tell you is the cost gap, and it is smaller than the gap between the cheapest and most expensive seller of either one.

Two providers sell tirzepatide and publish no price

Oak lists a compounded GLP-1 and GIP product and quotes programmes "from as little as $119 a month" in its FAQ, without saying which product that figure covers. Its own comparison chart on the weight-loss page uses $190 a month. Neither number is attached to the dual-agonist product specifically.

Care Bare Rx lists an oral tirzepatide alongside oral semaglutide. Its weight-loss product page does not contain a dollar sign anywhere. Its FAQ says price varies by dose and medication and refers to "the listed prices", which are not listed. The only figure on the site is a home-page "starting at $199" with no billing period attached.

A provider that will not publish a price before the medical intake is asking you to hand over health information before you know what the treatment costs. That is a choice you can make, but make it deliberately. Full detail is in our Oak review and Care Bare Rx review.

If you want the FDA-approved version

Zepbound is the FDA-approved branded tirzepatide for weight management. Ro is the only provider in this comparison built around dispensing branded product and checking your insurance first. Its membership fee — $39 for the first month, then $149 a month, or as low as $74 a month if you prepay a year — does not include the medication.

That makes Ro impossible to rank against the compounded plans on a single number. If your insurance covers Zepbound, your total cost can be lower than any compounded plan in this table. If it does not, it can be several times higher. The Ro review explains what the membership does and does not buy.

Who should pay more, and who should not

Paying above $150 a month for compounded tirzepatide is defensible if

  • The provider gives you something specific for it — Direct Meds includes a dedicated licensed nurse and bulk 6 and 12-month pricing.
  • You want a format nobody cheap offers, such as a tablet.
  • You need a provider licensed in your state and the cheaper options are not.
  • You have read the refund terms and accept them, because at $299 or $349 a single non-refundable cycle is real money.

You are probably overpaying if

  • You are paying $349 for the same compounded molecule Trimi Health sells at $125, with no stated billing period and no published refund window.
  • Your provider prices by dose and you are still on the starting dose — the bill has not finished rising yet.
  • You are on a 21-day cycle and budgeting as though it were monthly.
  • You have insurance you have never asked about, and you have not checked whether branded Zepbound would be covered.

See CoreAge Rx current tirzepatide pricing See the annualised cost ranking

The CoreAge Rx link is an affiliate link. The ranking link is not.

How we sourced this

We read every figure above from the provider's own public pages — product and pricing pages, FAQs, terms of use and refund or cancellation policies — on 11 August 2026, and we annualised them ourselves using the billing interval each provider publishes. We have not been through any provider's checkout, so we are reporting what the documents say rather than what a bank statement shows. Where a provider does not publish a billing interval we say so instead of guessing, and the annual figure in that row assumes monthly billing purely so the row is comparable. Providers change pricing often. If you find a discrepancy, tell us on our contact page and we will check it and update the row.

Medical note

This is consumer purchasing information, not medical advice. GLP-1 medicines are prescription drugs with real risks and real contraindications, and nothing on this page has been clinically reviewed. Talk to a clinician who knows your history before starting, changing or stopping treatment. See our medical disclaimer.